David Mehalick
2022
In 2022, David Mehalick earned a total compensation of $361.6K as Chairman, CEO and President at Coeptis Therapeutics Holdings, a 67% increase compared to previous year.
Compensation breakdown
| Bonus | $75,000 |
|---|---|
| Salary | $286,615 |
| Total | $361,615 |
Mehalick received $286.6K in salary, accounting for 79% of the total pay in 2022.
Mehalick also received $75K in bonus.
Rankings
In 2022, David Mehalick's compensation ranked 4,855th out of 5,753 executives tracked by ExecPay. In other words, Mehalick earned more than 15.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,855 out of 5,753 | 16th |
Division Manufacturing | 2,691 out of 3,133 | 14th |
Major group Chemicals And Allied Products | 1,265 out of 1,419 | 11th |
Industry group Drugs | 1,190 out of 1,320 | 10th |
Industry Biological Products, Except Diagnostic Substances | 275 out of 291 | 6th |
Source: SEC filing on November 17, 2023.
Mehalick's colleagues
We found two more compensation records of executives who worked with David Mehalick at Coeptis Therapeutics Holdings in 2022.